Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Bullboard Posts
Post by islandphileon Oct 13, 2017 11:40am
175 Views
Post# 26809964

First Post

First PostHello all, I have been following the board along almost daily since March 2017. I have learned a lot so thanks to all the real contributors. TLT is a great opportunity... but I have some nagging concerns, perhaps we can discuss them? 

The big elephant in the room as I see it is this:

Some very smart people I have told about TLT have said the Big Pharma will never allow such a technology onto the market if it will destroy the "cancer business" they currently enjoy. Then there is the auto-immune response, which essentially "kills" future business for TLT itself in the very long run.

Purely speaking for all normal humans on the planet this technology could put an end to cancer, period, which is great for humanity, but not so great for corporate profits.

That said, I'm a share holder with a modest position, and awaiting the 6-month news has me in suspense!
Bullboard Posts